NCT06715254View on ClinicalTrials.gov

A Real-world Study of Tuberculosis Incidence in AS, PsA, or PsO Patients Treated With Secukinumab in Brazil

TerminatedOBSERVATIONAL
Enrollment

152

Participants

Timeline

Start Date

July 23, 2021

Primary Completion Date

November 30, 2023

Study Completion Date

November 30, 2023

Conditions
Tuberculosis
Trial Locations (1)

07936

Novartis, East Hanover

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY